x
Breaking News
0

Biocon Ltd. (BION)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
521.20 +7.65    +1.49%
15:58:04 - Closed. Currency in INR ( Disclaimer )
Type: Equity
Market: India
ISIN: INE376G01013 
S/N: BIOCON
  • Volume: 1,032,766
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 515.70 - 523.40
Start Trading
Biocon 521.20 +7.65 +1.49%

BION Overview

 
Information about the Biocon Ltd. Share. You can find more details by going to one of the sections listed on this page such as historical data, charts, technical analysis and others.
Loading
Last Update:
  • 1 Day
  • 1 Week
  • 1 Month
  • 3 Months
  • 6 Months
  • 1 Year
  • 5 years
  • Max
Prev. Close513.55
Day's Range515.7 - 523.4
Revenue38.78B
Open517
52 wk Range293.9 - 530.8
EPS7.55
Volume1,032,766
Market Cap308.13B
Dividend (Yield)1 (0.19%)
Average Volume (3m)3,293,448
P/E Ratio67.98
Beta0.24
1-Year Change66.93%
Shares Outstanding600,000,000
Next Earnings DateJan 24, 2018
What is your sentiment on Biocon?
or
Market is currently closed. Voting is open during market hours.

Technical Summary

Type 5 mins 15 mins Hourly Daily Monthly
Moving Averages Strong Buy Buy Buy Buy Buy
Technical Indicators Strong Buy Strong Buy Strong Buy Strong Buy Strong Buy
Summary Strong Buy Strong Buy Strong Buy Strong Buy Strong Buy

Candlestick Patterns

 

Filter Table By:

Candle Sticks Characteristics:

Time Frame
Type
Pattern Indication
Reliability
Pattern Timeframe Reliability Candles Ago Candle Time
Emerging Patterns
Three Outside Up 30 Current
Deliberation Bearish 1W Current
Doji Star Bearish 1W Current
Completed Patterns
Bullish Engulfing 30 2 Dec 15, 2017 14:30
Rising Three Methods 15 4 Dec 15, 2017 14:45
Engulfing Bearish 1W 7 Oct 22, 2017

Biocon Ltd. News & Analysis

Biocon Ltd. Quotes

Exchange Last Bid Ask Volume Change % Currency Time
  NSE 521.20 0.00 0.00 1,032,766 +1.49% INR 15:58:04  
  NSE 520.05 0.00 0.00 4,330,800 +1.60% INR 15:29:00  
  BSE 522.00 0.00 0.00 93,401 +1.78% INR 15:29:00  

Trending Stocks

Create Alert
Add to Portfolio
Add to/Remove from a Portfolio  
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

  Name Last High Low Chg. Chg. % Vol. Time
  Vedanta 298.00 299.90 289.95 +13.45 +4.73% 25.90M 15:55:38  
  Yes Bank 315.90 317.45 307.00 +12.00 +3.95% 20.57M 15:59:09  
  SBI 312.25 319.35 311.50 -1.75 -0.56% 16.05M 15:59:55  
  Dr. Reddy's Labs 2,371.50 2,380.00 2,316.45 +60.85 +2.63% 743.68K 15:49:59  
  Tata Steel Ltd 694.70 700.85 691.05 +8.95 +1.31% 3.16M 15:43:32  
  Reliance Industries 919.75 932.95 917.70 -1.75 -0.19% 11.16M 15:59:24  
  Mahindra & Mahindra 1,483.40 1,490.00 1,441.00 +51.80 +3.62% 3.55M 15:57:00  
  Hindalco Industries 242.75 243.95 239.10 +6.35 +2.69% 6.29M 15:56:56  
  HDFC Bank 1,873.45 1,888.00 1,855.50 +35.40 +1.93% 3.11M 15:59:32  
  Bombay Dyeing&Mfg. 266.75 269.85 230.70 +38.45 +16.84% 18.71M 15:59:49  

Biocon Ltd. Company Profile

IndustryBiotechnology & Drugs
SectorHealthcare
Employees

4832

Equity Type

ORD

Biocon Limited is a biopharmaceutical company. The Company focuses to reduce therapy costs of chronic diseases like autoimmune, diabetes, and cancer. Through its products and research services it is enabling access to affordable healthcare for patients, partners and healthcare systems across the globe. The Company has developed and taken a range of Novel Biologics, Biosimilars, differentiated Small Molecules and affordable Recombinant Human Insulin and Analogs from Lab to Market. The Company’s brands include INSUGEN (rh-insulin), BASALOG (Glargine), CANMAb (Trastuzumab), BIOMAb-EGFR (Nimotuzumab) and ALZUMAb (Itolizumab), an anti-CD6 monoclonal antibody. It has a pipeline of Biosimilars and Novel Biologics at various stages of development, including Insulin Tregopil, an oral insulin analog.

Read More

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

 
Are you sure you want to delete this chart?
 
Write your thoughts about Biocon Ltd.
 
Replace the attached chart with a new chart ?
Post
Post also to:
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.

Latest BION Comments

Raj Kishore
Raj Kishore Dec 13, 2017 6:11 GMT
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Should I sell unitech I'm going 9%loss
Reply
0 0
Rahul Choudhary
Rahul Choudhary Dec 01, 2017 10:09 GMT
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Buy biocon....price goes to 500
Reply
3 0
Anupkumar Tripathi
Anupkumar Tripathi Aug 18, 2017 15:09 GMT
Saved. See Saved Items.
This comment has already been saved in your Saved Items
SELL BIOCON TARGET 300 Aug Expiry expiry STOP LOSS 334
Reply
0 0
Show more comments
 
Are you sure you want to delete this chart?
 
 
Replace the attached chart with a new chart ?
Post 1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Continue with Google
or
Sign up with Email